Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-01

Clinical Trial Update: ED90 of 3% Chloroprocaine for Cervical Cerclage [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating the ED90 of 3% Chloroprocaine for cervical cerclage has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroprocaine (Chloroprocaine)

Snippet

Sponsor: Duke University | Conditions: Cerclage, Cervical | Phase 4 | Status: COMPLETED | Results posted: 2021-09-01